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Abstract 
AmpC is a group I, class C -lactamase present in most Enterobacteriaceae and in Pseudomonas aeruginosa and other nonfermenting gram-negative 
bacilli. The β-lactam class of antibiotics is one of the most important structural classes of antibacterial compounds and act by inhibiting the bacterial 
D ,D - transpeptidases that are responsible for the final step of peptidoglycan cross-linking. Our main aim in the study is to screen possible 
inhibitors against AmpC / β - lactamase (an enzyme responsible for antimicrobial activity in Pseudomonas aeruginosa), through virtual screening of 
1364  NCI (National Cancer Institute) diversity set II compounds. Homology Model of AmpC / β - lactamase was constructed using MODELLER 
and the Model was validated using PROCHECK and Verify 3D programs to obtain a stable structure, which was further used for virtual screening 
of NCI (National Cancer Institute) diversity set II compounds through molecular Docking studies using Autodock. The amino acid sequence of the 
β – lactamase was also subjected to ScanProsite web server to find any pattern present in the sequence. After the prediction of  3-dimensional model 
of AmpC/ β-lactamase, the possible Active sites of  β – lactamase were determined using LIGSITE
csc and CastP web servers simultaneously. The 
Docked complexes were validated and Enumerated based on the Autodock Scoring function to pick out the best inhibitor based on Autodock energy 
score. Thus from the entire 1364 NCI diversity set II compounds which were Docked, the best four docking solutions were selected 
(ZINC12670903, ZINC17465965, ZINC11681166 and ZINC13099024). Further the Complexes were analyzed through LIGPLOT for their 
interaction for the 4 best docked NCI diversity set II compounds. Thus from the Complex scoring and binding ability it is deciphered that these NCI 
diversity set II compounds could be promising inhibitors for Pseudomonas aeruginosa  using AmpC / β - lactamase as Drug target yet 
pharmacological studies have to confirm it. 
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Background: 
Pseudomonas aeruginosa is an opportunistic pathogen, meaning that it 
exploits some break in the host defenses to initiate an infection. In fact, 
Pseudomonas aeruginosa is the epitome of an opportunistic pathogen of 
humans. The bacterium almost never infects uncompromised tissues, 
yet there is hardly any tissue that it cannot infect if the tissue defenses 
are compromised in some manner. It causes urinary tract infections, 
respiratory system infections, dermatitis, soft tissue infections, 
bacteremia, bone and joint infections, gastrointestinal infections and a 
variety of systemic infections, particularly in patients with severe burns 
and in cancer and AIDS patients who are immunosuppressed. 
Pseudomonas aeruginosa infection is a serious problem in patients 
hospitalized with cancer, cystic fibrosis, and burns. The case fatality 
rate in these patients is near 50 percent. [1, 2, 3].  Pseudomonas 
aeruginosa is intrinsically resistant to many antibiotics, or can develop 
resistance during treatment with consequent high mortality, and is, 
increasingly, a cause of infection in immunocompromised patients. The 
most relevant mechanism for the development of resistance to the 
antipseudomonal penicillins (such as ticarcillin or piperacillin) and 
cephalosporins (such as ceftazidime) is the selection of mutations 
leading to the hyperproduction of the chromosomal cephalosporinase 
AmpC [4, 5, 6]. AmpC is a group I, class C -lactamase present in most 
Enterobacteriaceae and in P. aeruginosa and other nonfermenting gram-
negative bacilli [7, 8]. The β-lactam class of antibiotics is one of the 
most important structural classes of antibacterial compounds and act by 
inhibiting the bacterial D ,D -transpeptidases that are responsible for the 
final step of peptidoglycan cross-linking. The resistance mechanism in 
bacteria to β - lactams is the production of β-lactamases that catalyze 
the hydrolysis of the β -lactam ring, preventing their interaction with the 
D,D-transpeptidases. During treatment with lactams, resistant mutants 
showing constitutive high levels of AmpC production are frequently 
selected, leading to therapeutic failure [9]. Thus due to emergence of 
multidrug resistant and extremely drug resistant strains of Pseudomonas 
aeruginosa  makes searching for drugs that are effective against these 
strains imperative. 
 
Our main aim in the study is to screen possible inhibitors against AmpC 
/  β - lactamase (an enzyme responsible for antimicrobial activity in 
Pseudomonas aeruginosa), through virtual screening of 1364 NCI 
(National Cancer Institute) diversity set II compounds. NCI Diversity 
Set II is a collection of 1,364 compounds chosen (from 140,000 open 
compounds in the NCI chemical repository with more than or equal to 
250 mg inventory) to cover a large, diverse range of molecular scaffolds 
and pharmacophore features, while also being relatively rigid. All 
compounds in the Diversity Set II have five or fewer rotatable bonds, 




Comparative modeling of AmpC / β – lactamase 
As the tertiary structure of  AmpC/ β-lactamase is not available in the 
structure databases the structure was predicted by comparative 
modelling approach. The comparative modelling of P. aeruginosa β – 
lactamase was done using MODELLER 9v6 [11] and five models were 
generated. The peptide sequence of  P. aeruginosa β–lactamase was 
retrieved from UniProt Knowledge Base, http://www.uniprot.org, 
(UniProt acc. No.  P24735), ranging from 27 to 397 residues. ClustalW 
was used to produce alignment between the P. aeruginosa  β – 
lactamase sequence and the sequence of the templates (PDB: 2QZ6 and 
1ZKJ) chosen from PDB BLAST hit. The predicted 3-D structures were 
evaluated using the PROCHECK [12] and Verify 3D programs [13]. 
 
Pattern detection in the sequence 
The amino acid sequence of the β – lactamase was subjected to 
ScanProsite web server [14] to find any pattern present in the sequence.  
 
Active Site Determination: 
After the prediction of 3-dimensional model of AmpC/ β-lactamase, the 
possible Active sites of  β – lactamase were determined using 
LIGSITE
csc.[15] and CastP [16] web servers simultaneously. 
LIGSITE
csc is based on the notion of surface-solvent-surface events and 
the degree of conservation of the involved surface residues where as 
CastP server uses the weighted Delaunay triangulation and the alpha 
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complex for shape measurements. It provides identification and 
measurements of surface accessible pockets as well as interior 
inaccessible cavities, for proteins and other molecules. 
 
Figure 1: (A) The final model of AmpC / β – lactamase; (B) Validation of the model using Ramachandran plot computed with the PROCHECK 
program with 95.1 % of the residues in the most favored regions. 
 
 
Figure 2: Active sites are shown. (A) The red sphere shows the coordinates of the center of the active site predicted by Ligsite program. (B) Blue 
spheres show the location and the area covered by the most appropriate active site as predicted by CastP program. 
 
Virtual Screening of NCI Diversity Set II against β – lactamase 
using molecular docking: 
The ligand molecules of  NCI Diversity Set II were obtained from 
ZINC database, a free database of commercially-available compounds 
for virtual screening in mol2 format, provided by the Shoichet 
Laboratory in the Department of Pharmaceutical Chemistry at the 
University of California, San Francisco (UCSF) [17]. Autodock4 
program was used for molecular docking along with the help of the 
python scripts provided in the AutodockTools package for the 
preparation of the ligand, receptor, grid and dock parameter files. 
AutoDock4 uses Monte Carlo (MC) simulated annealing and 
Lamarckian genetic algorithm (LGA) to create a set of possible 
conformations, i.e. each string (coding for an individual in the 
population) passes on some of the characteristics it has acquired during 
its lifetime. LGA is used as a global optimizer and energy minimization 
as a local search method. Possible orientations are evaluated with 
AMBER force field model in conjunction with free energy scoring 
functions and a large set of protein-ligand complexes with known 
protein-ligand constants  [18]. The active site center obtained by active 
site determination programs was used as the grid center in the grid 
parameter file, rest all the parameters were set to default values. The 
entire process of file preparation and docking was automated using an 
in house Perl script. 
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Molecular interactions : 
The LIGPLOT tool was used to generate molecular level interactions in 




Figure 3: Receptor-ligand interaction is shown. (A) ZINC12670903 hydrogen bonded with Ser 64 OH, Lys 316 NH and Thr 317 OH at a distance 
of 2.79 Å, 2.75 Å and 2.53 Å, respectively whereas Gln 120, Tyr 151, Tyr 223, Ser 319, Thr 320 and Asn 321 are non-ligand residues involved in 
hydrophobic contact(s). (B) ZINC17465965 hydrogen bonded with Ser 64 OH, Arg 149 NH, Tyr 151 OH, Asn 153 NH, Thr 317  OH and Asn 347 
NH at a distance of 2.87 Å, 2.68 Å, 2.90 Å, 2.97 Å, 2.57 Å and 3.29 Å respectively whereas Ala 293, Ser 319 and Thr 320 are non-ligand residues 
involved in hydrophobic contact(s). (C) ZINC11681166 hydrogen bonded with Ser 64 OH, Tyr 151 OH and Asn 344 NH at a distance of 2.35 Å, 
2.44 Å and 2.79 Å respectively whereas Thr 290, Ala 293, Ser 319, Thr 320 and Asn 321 are non-ligand residues involved in hydrophobic 
contact(s). (D) ZINC13099024 hydrogen bonded with Ser 64 OH, Tyr 151 OH, Gly 214 NH and Thr 317 OH at distance of 2.76 Å, 3.09 Å, 3.25 Å 
and 2.79 Å respectively whereas Val 213, Tyr 223, Thr 320 and Asn 321 are non-ligand residues involved in hydrophobic contact(s). 
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Visualization:  
All the visualization of the structure files were done using PyMol 
molecular graphics system [20]. 
 
Discussion: 
The hypothetical protein models generated in the modeling procedure 
were analyzed online by submitting to NIH MBI Laboratory for 
Structural Genomics and Proteomics’ SAVES server. Validity reports 
generated by PROCHECK and Verfiy_3D judged accuracy of the 
protein models. A comparison of the results obtained from the above-
mentioned validation tools, showed that one of the models generated by 
Modeller is more acceptable in comparison to the others and was 
selected for further studies. For the final selected model Ramachandran 
plot generated by PROCHECK showed 95.1% residues in the most 
favored region (Figure 1). The compatibility of the atomic model (3D) 
with its own amino acid sequence (1D) computed by Verfy_3D 
reported 100.00% of the residues having an average 3D-1D score > 0.2 . 
 
After the validation, the sequence of the  β – lactamase was scanned for 
any pattern present in the sequence using ScanProsite. The regular 
expression generated by the scan ([FY] - E - [LIVM] - G - S - [LIVMG] 
- [SA] - K ) suggested β – lactamase class-C active site region with first 
Serine residue as the catalytic residue. Active sites in the modeled 
protein structure were detected using LIGSITE
csc and CastP webserver. 
The LIGSITE
csc and CastP programs detected all the possible pockets in 
the structure which were compared with active site location from the 
homologous structures complexed with the substrates available in the 
PDB. Residues within the 5 A radius of the coordinates of the center of 
the active site detected by the LIGSITE
csc was also studied for the 
catalytic Serine residue as well as other residues found conserved in the 
ScanProsite. The various pockets obtained by the CastP program were 
also looked for the conserved residues and the spatial location of the 
pockets found by the program, the 2
nd pocket detected was found better 
in all respects hence it was chosen as the most biologically favorable 
site for Docking study and other Identified Active sites were neglected 
(Figure 2).  
 
A set of 1364 compounds available in NCI Diversity Set II were 
obtained from ZINC database in mol2 format, the individual mol2 files 
converted into pdbqt file supported by Autodock4 using the python 
script prepare_ligand4.py available in Autodock Tools package. The 
receptor molecule was also converted into pdbqt format using 
prepare_receptor4.py script of Autodock Tools. The coordinates 
generated by the Ligsite in the grid parameter file, the grid was 
generated using Autogrid4 available in the Autodock4 suite. Docking of 
1364 compounds was performed using Autodock4, the entire process of 
format conversion of files, preparation of grid and dock parameter files 
were automated using an in house Perl script. The algorithm 
exhaustively searches the entire rotational and translational space of the 
Ligand with respect to the receptor. The various solutions evaluated by 
a score giving Estimated Free Energy of Binding which is a sum total of 
Final Intermolecular Energy (vdW + Hbond + desolv Energy, 
Electrostatic Energy), Final Total Internal Energy, Torsional Free 
Energy and Unbound System's Energy of the Ligand in the protein 
environment. The best four docking solutions based on the energy 
scores were selected (Table 1 in supplementary material). 
 
To understand the interaction between  β – lactamase and the four 
compounds from the NCI Diversity Set II, complexes were generated 
using AutodockTools for outputs of Autodock solutions. LIGPLOT 
were run for all the four complexes (Figure 3). It is evident from the 
analysis of the Docked complex that the Ligands are located in the 
center of the Active site, and is stabilized by hydrogen bonding 
interactions. The interaction analysis shows that Ser 64, Tyr 151 and 
Thr 317 are important anchoring residues for  β – lactamase and the 
main contributors towards compound interaction. Though the 
interaction energy does not include the contribution from the water of 
the extended compound structure, this preliminary data along with the 
list of hydrogen bond interactions between the compounds and the 
Active site residues clearly supports that Ser 64, Tyr 151 and Thr 317 
are more preferred residues in binding. 
 
Conclusion: 
AmpC/β – lactamase is shown to be most potent cause for antimicrobial 
resistance in Pseudomonas aeruginosa. In this work, predicted 3-
dimensional Model of AmpC / β – lactamase was used for Virtual 
Screening of NIC Diversity Set II compounds. Docking results indicate 
that out of 1364 compounds, there were four inhibitory compounds for 
AmpC/β–lactamase as target for antimicrobial resistance in 
Pseudomonas aeruginosa. Hydrogen bonding proved to play an 
important role for the structure and function of biological molecules, 
especially for inhibition in a complex. Thus our study confirms that 
ligand molecules having the following ZINC Ids  ZINC12670903, 
ZINC17465965, ZINC11681166 and ZINC13099024 are potential 
inhibitor for AmpC /  β – lactamase as target for antimicrobial 
resistance in Pseudomonas aeruginosa. Yet to confirm it to be 
promising, Pharmacological studies need to be performed. 
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Table 1: Estimated Free Energy of Binding of the top four ligands 
S. No.  Ligands (ZINC ID)  Estimated Free Energy of Binding 
1. ZINC12670903  -8.54 
2. ZINC17465965  -8.48 
3. ZINC11681166  -8.14 
4. ZINC13099024  -8.10 
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